Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 29;219(4):517-525.
doi: 10.1093/infdis/jiy499.

Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo

Nicole A Hoff  1 , Patrick Mukadi  2   3 , Reena H Doshi  1 , Matthew S Bramble  4 , Kai Lu  5   6 , Adva Gadoth  1 , Cyrus Sinai  1 , D'Andre Spencer  1 , Bradley P Nicholson  7 , Russell Williams  8 , Matthias Mossoko  9 , Benoit Ilunga-Kebela  9 , Joseph Wasiswa  8   9 , Emile Okitolonda-Wemakoy  10 , Vivian H Alfonso  1 , Imke Steffen  5   6 , Jean-Jacques Muyembe-Tamfum  2   3 , Graham Simmons  5   6 , Anne W Rimoin  1
Affiliations

Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo

Nicole A Hoff et al. J Infect Dis. .

Abstract

Healthcare settings have played a major role in propagation of Ebola virus (EBOV) outbreaks. Healthcare workers (HCWs) have elevated risk of contact with EBOV-infected patients, particularly if safety precautions are not rigorously practiced. We conducted a serosurvey to determine seroprevalence against multiple EBOV antigens among HCWs of Boende Health Zone, Democratic Republic of the Congo, the site of a 2014 EBOV outbreak. Interviews and specimens were collected from 565 consenting HCWs. Overall, 234 (41.4%) of enrolled HCWs were reactive to at least 1 EBOV protein: 159 (28.1%) were seroreactive for anti-glycoprotein immunoglobulin G (IgG), 89 (15.8%) were seroreactive for anti-nucleoprotein IgG, and 54 (9.5%) were VP40 positive. Additionally, sera from 16 (2.8%) HCWs demonstrated neutralization capacity. These data demonstrate that a significant proportion of HCWs have the ability to neutralize virus, despite never having developed Ebola virus disease symptoms, highlighting an important and poorly documented aspect of EBOV infection and progression.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Health facility locations of surveyed healthcare workers in Boende health zone, Tshuapa province, Democratic Republic of the Congo. Abbreviation: HCW, healthcare worker.
Figure 2.
Figure 2.
Venn diagram of overlapping immunoreactivity assay measures in healthcare workers who participated in the Boende outbreak, Democratic Republic of the Congo, 2014. Abbreviations: GP, glycoprotein; NP, nucleoprotein; VP40, Ebola virus matrix protein.
Figure 3.
Figure 3.
Immunoreactivity assay measures by contact type (inferred from occupation) for 565 healthcare workers. A, Antibody titer values measuring reactivity to Ebola virus (EBOV) glycoprotein using enzyme-linked immunosorbent assay (ELISA). B, Antibody titers measuring reactivity to EBOV nucleoprotein using ELISA. C, Relative luciferase signal obtained after immunoprecipitating EBOV VP40-Luc using participant serum samples. D, Neutralization capacity to at least 50% of input control. Abbreviations: GP, glycoprotein; NP, nucleoprotein; RLU, Relative Luminescence Units; VP40, Ebola virus matrix protein.
See this image and copyright information in PMC

Comment in

  • Ebola Mysteries and Conundrums.
    Garry RF. Garry RF. J Infect Dis. 2019 Jan 29;219(4):511-513. doi: 10.1093/infdis/jiy476. J Infect Dis. 2019. PMID: 30085161 Free PMC article. No abstract available.

References

    1. International Commission. Ebola hemorrhagic fever in Zaire, 1976. Geneva, Switzerland: World Health Organization, 1978.
    1. World Health Organization. Ebola haemorrhagic fever in Sudan, 1976. Geneva, Switzerland: World Health Organization, 1978. - PMC - PubMed
    1. Centers for Disease Control and Prevention. Outbreaks chronology: Ebola virus disease. https://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html. Accessed 14 May 2018.
    1. Evans DK, Goldstein M, Popova A. Health-care worker mortality and the legacy of the Ebola epidemic. Lancet Glob Health 2015; 3:e439–40. - PubMed
    1. Osterholm MT, Moore KA, Kelley NS, et al. . Transmission of Ebola viruses: what we know and what we do not know. MBio 2015; 6:e00137. - PMC - PubMed

Publication types